Brady F. Cress

3.3k total citations · 2 hit papers
39 papers, 2.2k citations indexed

About

Brady F. Cress is a scholar working on Molecular Biology, Cell Biology and Ecology. According to data from OpenAlex, Brady F. Cress has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Ecology. Recurrent topics in Brady F. Cress's work include CRISPR and Genetic Engineering (16 papers), Proteoglycans and glycosaminoglycans research (8 papers) and Glycosylation and Glycoproteins Research (7 papers). Brady F. Cress is often cited by papers focused on CRISPR and Genetic Engineering (16 papers), Proteoglycans and glycosaminoglycans research (8 papers) and Glycosylation and Glycoproteins Research (7 papers). Brady F. Cress collaborates with scholars based in United States, China and Australia. Brady F. Cress's co-authors include Mattheos Koffas, Robert J. Linhardt, Jennifer A. Doudna, Jacob A. Englaender, Gavin J. Knott, J. Andrew Jones, Jillian F. Banfield, Basem Al-Shayeb, Patrick Pausch and Steven E. Jacobsen and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Brady F. Cress

37 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CRISPR-CasΦ from huge phages is a hypercompact genome editor

2020 394 citations Patrick Pausch, Basem Al-Shayeb et al. Science profile →
Controlling and enhancing CRISPR systems

2020 136 citations Haridha Shivram, Brady F. Cress et al. Nature Chemical Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brady F. Cress United States	22	1.8k	304	240	207	206	39	2.2k
José Arnau Denmark	22	1.2k 0.6×	228 0.8×	166 0.7×	349 1.7×	243 1.2×	42	1.8k
Ilya А. Osterman Russia	25	1.2k 0.7×	312 1.0×	319 1.3×	160 0.8×	135 0.7×	107	1.8k
Pep Charusanti United States	19	1.8k 1.0×	351 1.2×	205 0.9×	137 0.7×	188 0.9×	30	2.4k
Rafael Silva‐Rocha Brazil	28	2.0k 1.1×	586 1.9×	264 1.1×	390 1.9×	293 1.4×	94	2.6k
Yaojun Tong China	21	1.4k 0.8×	183 0.6×	138 0.6×	204 1.0×	267 1.3×	37	2.1k
Yan Zheng China	30	1.2k 0.7×	148 0.5×	103 0.4×	243 1.2×	411 2.0×	90	2.6k
Soo-Keun Choi South Korea	24	1.1k 0.6×	364 1.2×	267 1.1×	449 2.2×	156 0.8×	73	1.7k
Anne E. Clatworthy United States	16	1.2k 0.7×	297 1.0×	215 0.9×	129 0.6×	71 0.3×	27	2.3k
Karl Friehs Germany	26	1.4k 0.7×	360 1.2×	189 0.8×	137 0.7×	224 1.1×	78	1.8k
Aiying Li China	23	1.2k 0.6×	181 0.6×	197 0.8×	351 1.7×	390 1.9×	77	1.9k

Countries citing papers authored by Brady F. Cress

Since Specialization

Citations

This map shows the geographic impact of Brady F. Cress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brady F. Cress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brady F. Cress more than expected).

Fields of papers citing papers by Brady F. Cress

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brady F. Cress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brady F. Cress. The network helps show where Brady F. Cress may publish in the future.

Co-authorship network of co-authors of Brady F. Cress

This figure shows the co-authorship network connecting the top 25 collaborators of Brady F. Cress. A scholar is included among the top collaborators of Brady F. Cress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brady F. Cress. Brady F. Cress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Sara J., Emily C. Pierce, Adam M. Deutschbauer, et al.. (2026). Identification of proteins influencing CRISPR-associated transposases for enhanced genome editing. Science Advances. 12(1). eaea1429–eaea1429.

Adler, Benjamin A., et al.. (2025). Phage-based delivery of CRISPR-associated transposases for targeted bacterial editing. Proceedings of the National Academy of Sciences. 122(30). e2504853122–e2504853122. 6 indexed citations

Irvine, Julie, et al.. (2025). Generating functional plasmid origins with OriGen. Nucleic Acids Research. 53(22).

Enüstün, Eray, Emily G. Armbruster, Erica A. Birkholz, et al.. (2024). An essential and highly selective protein import pathway encoded by nucleus-forming phage. Proceedings of the National Academy of Sciences. 121(19). e2321190121–e2321190121. 9 indexed citations

Nolan, Nicholas, et al.. (2023). Systematic and scalable genome-wide essentiality mapping to identify nonessential genes in phages. PLoS Biology. 21(12). e3002416–e3002416. 13 indexed citations

Adler, Benjamin A., Brady F. Cress, Vivek K. Mutalik, et al.. (2022). Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing. Nature Microbiology. 7(12). 1967–1979. 72 indexed citations

Al-Shayeb, Basem, Petr Skopintsev, Katarzyna M. Soczek, et al.. (2022). Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors. Cell. 185(24). 4574–4586.e16. 93 indexed citations

Otoupal, Peter B., Brady F. Cress, Jennifer A. Doudna, & Joseph S. Schoeniger. (2022). CRISPR-RNAa: targeted activation of translation using dCas13 fusions to translation initiation factors. Nucleic Acids Research. 50(15). 8986–8998. 36 indexed citations

Shivram, Haridha, Brady F. Cress, Gavin J. Knott, & Jennifer A. Doudna. (2020). Controlling and enhancing CRISPR systems. Nature Chemical Biology. 17(1). 10–19. 136 indexed citations breakdown →

10.

Pausch, Patrick, Basem Al-Shayeb, Connor A. Tsuchida, et al.. (2020). CRISPR-CasΦ from huge phages is a hypercompact genome editor. Science. 369(6501). 333–337. 394 indexed citations breakdown →

11.

Knott, Gavin J., Brady F. Cress, Junjie Liu, et al.. (2019). Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a. eLife. 8. 47 indexed citations

12.

Cress, Brady F., Ujjwal Bhaskar, Asher Williams, et al.. (2019). Heavy Heparin: A Stable Isotope‐Enriched, Chemoenzymatically‐Synthesized, Poly‐Component Drug. Angewandte Chemie. 131(18). 6023–6027. 2 indexed citations

13.

Kizer, Megan E., Peiqin Li, Brady F. Cress, et al.. (2018). RNA Aptamers with Specificity for Heparosan and Chondroitin Glycosaminoglycans. ACS Omega. 3(10). 13667–13675. 8 indexed citations

14.

Ito, Takeshi, Masatoshi Murai, Yuki Kitazumi, et al.. (2017). Identification of the binding sites for ubiquinone and inhibitors in the Na+-pumping NADH-ubiquinone oxidoreductase from Vibrio cholerae by photoaffinity labeling. Journal of Biological Chemistry. 292(19). 7727–7742. 24 indexed citations

15.

Jones, J. Andrew, Shannon M. Collins, Abhijit N. Shirke, et al.. (2017). Complete Biosynthesis of Anthocyanins Using E. coli Polycultures. mBio. 8(3). 165 indexed citations

16.

Ibrahim, Mohammad H.A., Brady F. Cress, Robert J. Linhardt, Mattheos Koffas, & Richard A. Gross. (2016). Draft Genome Sequence of Bacillus subtilis Ia1a, a New Strain for Poly-γ-Glutamic Acid and Exopolysaccharide Production. Genome Announcements. 4(6). 1 indexed citations

17.

Cress, Brady F., J. Andrew Jones, Daniel C. Kim, et al.. (2016). Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes inEscherichia coli. Nucleic Acids Research. 44(9). 4472–4485. 72 indexed citations

18.

Xing, Zhang, So Young Kim, Ruitong Wang, et al.. (2016). Synthesis and biological evaluation of 5,7-dihydroxyflavanone derivatives as antimicrobial agents. Bioorganic & Medicinal Chemistry Letters. 26(13). 3089–3092. 23 indexed citations

19.

Cress, Brady F., Jacob A. Englaender, Wenqin He, et al.. (2013). Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiology Reviews. 38(4). 660–697. 196 indexed citations

20.

Cress, Brady F., et al.. (2013). Draft Genome Sequence of Escherichia coli Strain ATCC 23502 (Serovar O5:K4:H4). Genome Announcements. 1(2). e0004613–e0004613. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact